Countdown to CME (CME) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Core Insights - CME Group (CME) is expected to report quarterly earnings of $2.57 per share, reflecting a year-over-year increase of 14.2$1.55 billion, indicating a 15.6% increase compared to the same quarter last year [1] - The consensus EPS estimate has been revised upward by 2.7% in the past 30 days, showcasing analysts' reassessment of their initial estimates [1] Revenue Estimates - 'Revenues- Other' are expected to reach $104.36 million, representing a 23.2$1.26 billion, indicating a 16% increase year-over-year [2] - 'Revenues- Market data and information services' are projected to be $175.74 million, suggesting a 4.9$414.55 million, reflecting an 18.1% increase from the prior-year quarter [3] - 'Revenues- Clearing and transaction fees - Foreign exchange' are expected to be $49.93 million, indicating a 6.5% increase year-over-year [3] Average Daily Volume - The consensus for 'Average daily volume (including NYMEX and COMEX)' is projected at 26,245.30 thousand, compared to 22.35 million in the same quarter last year [3] - 'Average daily volume - Metals (including NYMEX and COMEX)' is estimated at 723.34 thousand, up from 528 thousand in the same quarter last year [3] - 'Average daily volume - Interest rates (including NYMEX and COMEX)' is expected to reach 13,394.10 thousand, compared to 10.97 million in the same quarter last year [4] - 'Average daily volume - Equity indexes (including NYMEX and COMEX)' is projected at 6,923.93 thousand, compared to 6.35 million in the prior year [4] - 'Average daily volume - Foreign exchange (including NYMEX and COMEX)' is estimated at 1,024.33 thousand, up from 942 thousand year-over-year [4] - 'Average daily volume - Energy (including NYMEX and COMEX)' is expected to be 2,489.19 thousand, compared to 2.13 million in the same quarter last year [4] - 'Average daily volume - Agricultural commodities (including NYMEX and COMEX)' is projected at 1,690.61 thousand, compared to 1.43 million in the same quarter last year [5] Stock Performance - CME shares have returned +5.8% over the past month, outperforming the Zacks S&P 500 composite's +3.8% change [6] - CME holds a Zacks Rank 2 (Buy), indicating expectations to outperform the overall market in the near future [6]